cervical cancer
ABL Diagnostics to Commercialize Institut Pasteur RNA Seq-Based HPV Test
The test detects messenger RNA of human papillomavirus to discover active infections and precancerous lesions.
The firm recently announced agreements with Labcorp and Quest Diagnostics to provide its devices for self-collection of vaginal swab specimens.
Researchers have begun validating the new method that can reduce lab contamination and obviate the need for lyophilization.
Teal Health Closes $10M in Seed Funding to Support Self-Collected Cervical Cancer Test
The at-home collection device is for the detection of human papillomavirus and recently received breakthrough device designation from the FDA.
Top Five Articles on 360Dx Last Week: Detact Dx Nabs Gates Awards; November FDA Clearances; More
Last week, readers were most interested in a story about Gates Foundation awards to Detact Diagnostics to further develop a POC system and assays to detect infectious diseases.
Nov 27, 2024
Jan 29, 2024
Oct 28, 2021
Mar 16, 2021